The Other Stem Cell Debate
By Jamie Shreeve,
The New York Times
| 04. 10. 2005
Except for the three million human brain cells injected into his
cranium, XO47 is just an average green vervet monkey. He weighs about
12 pounds and measures 34 inches from the tip of his tail to the
sutured incision on the top of his head. His fur is a melange of black,
yellow and olive, with white underparts and a coal-black face. Until
his operation, two days before I met him, he was skittering about an
open-air enclosure on the grounds of a biomedical facility on the
Caribbean island of St. Kitts. Afterward, he was caged in a hut shared
with half a dozen other experimental monkeys, all of whom bore
identical incisions in their scalps. Judging from the results of
previous experiments, the human neural stem cells inserted into their
brains would soon take hold and begin to grow, their fibers reaching
out to shake hands with their monkey counterparts. The green vervets'
behavior was, and will remain, all monkey. To a vervet, eye contact
signals aggression, and when I peered into X047's cage, he took
umbrage, vigorously bobbing...
Related Articles
By Gina Kolata, The New York Times | 06.20.2025
A single infusion of a stem cell-based treatment may have cured 10 out of 12 people with the most severe form of type 1 diabetes. One year later, these 10 patients no longer need insulin. The other two patients need...
By Christina Jewett, The New York Times | 06.05.2025
Health Secretary Robert F. Kennedy Jr. recently declared that he wanted to expand access to experimental therapies but conceded that they could be risky or fraudulent.
In a podcast with Gary Brecka, who describes himself as a longevity expert...
By Mike Baker, The New York Times | 02.25.2025
As investigators struggled for weeks to find who might have committed the brutal stabbings of four University of Idaho students in the fall of 2022, they were focused on a key piece of evidence: DNA on a knife sheath that...
By David Jensen, Capitol Weekly | 02.19.2025
California scientists took what looked like an $800 million hit last week in their efforts to develop revolutionary treatments and cures for diseases ranging from cancer to diabetes.
It was a jab from the Trump administration, one that generated apocalyptic...